2019
DOI: 10.1097/corr.0000000000001106
|View full text |Cite
|
Sign up to set email alerts
|

Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Non-oncologic Conditions After Distal Femur Replacement?

Abstract: Background Distal femur replacement is frequently used for limb salvage after bone tumor resections. It is also used in patients with severe bone loss because of traumatic conditions or revision TKA. Some studies on distal femur replacement reported on revision-free survival without distinguishing between patients with oncologic diagnoses and those without, although these patients might be incomparable because of their differences in important patient- and disease-specific characteristics. This may… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 37 publications
0
11
0
1
Order By: Relevance
“…A recent retrospective competing risk analysis of 229 distal femoral replacements performed over 33 years demonstrated a lower risk for reoperation in the oncologic cohort, and better survivorship of cemented stems versus cementless in the oncologic cohort. 56 However, the authors recommended that these groups be analyzed separately given the differences in age and disease indication. Berend and Lombardi demonstrated no revisions for aseptic loosening in a retrospective series of 39 non-oncologic distal femoral replacements with 55% of the cohort utilizing cemented femoral stems.…”
Section: Outcomes Of Non-oncologic Distal Femoral Replacementsmentioning
confidence: 99%
“…A recent retrospective competing risk analysis of 229 distal femoral replacements performed over 33 years demonstrated a lower risk for reoperation in the oncologic cohort, and better survivorship of cemented stems versus cementless in the oncologic cohort. 56 However, the authors recommended that these groups be analyzed separately given the differences in age and disease indication. Berend and Lombardi demonstrated no revisions for aseptic loosening in a retrospective series of 39 non-oncologic distal femoral replacements with 55% of the cohort utilizing cemented femoral stems.…”
Section: Outcomes Of Non-oncologic Distal Femoral Replacementsmentioning
confidence: 99%
“…One of the most challenging problems following debridement of infected tissue is bone loss and can result in a large metaphyseal bone defect with loss of the femoral condyles that can even extent to the diaphysis [ 9 , 14 ]. For such defects, modular megaprosthetic reconstruction, of the distal femur can be considered [ 2 , 14 , 25 ] based on the long-term experience from tumor surgery [ 12 , 13 , 24 ]. However, due to the expected high revision rates, these procedures should be considered as salvage treatments [ 1 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Henderson classi ed complications into ve types [9], with aseptic loosening being the most common [1,10,11]. More patients are having prosthesis revision surgery because of aseptic loosening, but the revision failure rate is also increasing [12][13][14][15],which is mainly due to the recurrence of aseptic loosening [16]. We also found these problems in the revision of distal femur prosthesis.…”
Section: Introductionmentioning
confidence: 75%